UniProt ID | FAKD5_HUMAN | |
---|---|---|
UniProt AC | Q7L8L6 | |
Protein Name | FAST kinase domain-containing protein 5, mitochondrial | |
Gene Name | FASTKD5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 764 | |
Subcellular Localization | Mitochondrion matrix, mitochondrion nucleoid . Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. | |
Protein Description | Plays an important role in the processing of non-canonical mitochondrial mRNA precursors. [PubMed: 25683715] | |
Protein Sequence | MAATLKSLKLVRYRAFCSPSAFGAVRSVSYWNVSSTQHGGQDPPEHISLCHSAKKVKNICSTFSSRRILTTSSAHPGLEFSKTSSSKASTLQLGSPRATGVDEEDVEVFDSFENMRVFLQLRPEYRVHSYNASETSQLLSVSEGELILHKVRVNQNNLQAQVIVDYLCKLSSLPAEQHPVLLGSTSFALLCQLSVKKIQLFDTQDLINVLKAFVILGIPHSHSMLDVYETKCCHQVWEMNMDQLLLVADLWRYLGRKVPRFLNIFSSYLNLHWKDLSLSQLVHLIYVIGENRQVSQDLMQKLESLILKYIDLINLEEVGTICLGFFKSSTNLSEFVMRKIGDLACANIQHLSSRSLVNIVKMFRFTHVDHINFMKQIGEIAPQRIPSLGVQGVMHLTLYCSALRFLNEGVMNAVAASLPPRVAHCRSKDVAKILWSFGTLNYKPPNAEEFYSSLISEIHRKMPEFNQYPEHLPTCLLGLAFLEYFPVELIDFALSPGFVRLAQERTKFDLLKELYTLDGTVGIECPDYRGNRLSTHLQQEGSELLWYLAEKDMNSKPEFLETVFLLETMLGGPQYVKHHMILPHTRSSDLEVQLDVNLKPLPFNREATPAENVAKLRLEHVGVSLTDDLMNKLLKGKARGHFQGKTESEPGQQPMELENKAAVPLGGFLCNVADKSGAMEMAGLCPAACMQTPRMKLAVQFTNRNQYCYGSRDLLGLHNMKRRQLARLGYRVVELSYWEWLPLLKRTRLEKLAFLHEKVFTSAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MAATLKSLKLV ----CCCHHHHHHHE | 25.77 | 24719451 | |
7 | Phosphorylation | -MAATLKSLKLVRYR -CCCHHHHHHHEEEE | 33.57 | 25159151 | |
61 | Phosphorylation | KKVKNICSTFSSRRI HHHHHHHHHCCCCEE | 28.79 | 29083192 | |
62 | Phosphorylation | KVKNICSTFSSRRIL HHHHHHHHCCCCEEE | 24.11 | 29083192 | |
64 | Phosphorylation | KNICSTFSSRRILTT HHHHHHCCCCEEEEC | 24.03 | 29083192 | |
65 | Phosphorylation | NICSTFSSRRILTTS HHHHHCCCCEEEECC | 22.76 | 29083192 | |
73 | Phosphorylation | RRILTTSSAHPGLEF CEEEECCCCCCCCCC | 28.62 | - | |
81 | Phosphorylation | AHPGLEFSKTSSSKA CCCCCCCCCCCCCCC | 26.16 | - | |
82 | Ubiquitination | HPGLEFSKTSSSKAS CCCCCCCCCCCCCCC | 58.72 | 22817900 | |
83 | Phosphorylation | PGLEFSKTSSSKAST CCCCCCCCCCCCCCE | 32.42 | - | |
87 | Ubiquitination | FSKTSSSKASTLQLG CCCCCCCCCCEEECC | 48.59 | 21906983 | |
89 | Phosphorylation | KTSSSKASTLQLGSP CCCCCCCCEEECCCC | 33.13 | 23186163 | |
90 | Phosphorylation | TSSSKASTLQLGSPR CCCCCCCEEECCCCC | 24.31 | 29396449 | |
95 | Phosphorylation | ASTLQLGSPRATGVD CCEEECCCCCCCCCC | 21.58 | 30266825 | |
99 | Phosphorylation | QLGSPRATGVDEEDV ECCCCCCCCCCHHHC | 38.73 | 18452278 | |
166 | Phosphorylation | QAQVIVDYLCKLSSL CHHHHHHHHHHHHCC | 11.78 | - | |
171 | Phosphorylation | VDYLCKLSSLPAEQH HHHHHHHHCCCHHHC | 18.47 | 28387310 | |
361 | Succinylation | RSLVNIVKMFRFTHV CHHHHHHHHHHCCCC | 28.64 | 23954790 | |
361 | Ubiquitination | RSLVNIVKMFRFTHV CHHHHHHHHHHCCCC | 28.64 | - | |
417 | Phosphorylation | VMNAVAASLPPRVAH HHHHHHHHCCCCCCC | 31.50 | 24719451 | |
436 | Phosphorylation | DVAKILWSFGTLNYK HHHHHHHHHCCCCCC | 15.45 | 29449344 | |
439 | Phosphorylation | KILWSFGTLNYKPPN HHHHHHCCCCCCCCC | 15.15 | 29449344 | |
442 | Phosphorylation | WSFGTLNYKPPNAEE HHHCCCCCCCCCHHH | 28.16 | 29449344 | |
451 | Phosphorylation | PPNAEEFYSSLISEI CCCHHHHHHHHHHHH | 10.71 | - | |
507 | Acetylation | RLAQERTKFDLLKEL HHHHHHHHHHHHHHH | 43.00 | 19608861 | |
507 | Malonylation | RLAQERTKFDLLKEL HHHHHHHHHHHHHHH | 43.00 | 26320211 | |
507 | Succinylation | RLAQERTKFDLLKEL HHHHHHHHHHHHHHH | 43.00 | 23954790 | |
608 | Phosphorylation | LPFNREATPAENVAK CCCCCCCCCHHHHHH | 20.48 | - | |
615 | Ubiquitination | TPAENVAKLRLEHVG CCHHHHHHHHHHHHC | 29.83 | 24816145 | |
646 | Phosphorylation | RGHFQGKTESEPGQQ CCCCCCCCCCCCCCC | 52.12 | 27732954 | |
648 | Phosphorylation | HFQGKTESEPGQQPM CCCCCCCCCCCCCCC | 55.08 | 27732954 | |
670 | S-nitrosylation | VPLGGFLCNVADKSG CCCCCCHHHCCCCCC | 3.43 | 19483679 | |
670 | S-nitrosocysteine | VPLGGFLCNVADKSG CCCCCCHHHCCCCCC | 3.43 | - | |
676 | Phosphorylation | LCNVADKSGAMEMAG HHHCCCCCCCHHHCC | 32.12 | - | |
692 | Phosphorylation | CPAACMQTPRMKLAV CHHHHHCCCCCEEEE | 5.98 | 27732954 | |
704 | Methylation | LAVQFTNRNQYCYGS EEEEECCCCCCEECC | 28.68 | - | |
721 | 2-Hydroxyisobutyrylation | LLGLHNMKRRQLARL HCCCCCCCHHHHHHH | 50.15 | - | |
730 | Phosphorylation | RQLARLGYRVVELSY HHHHHHCCEEEEHHH | 12.58 | - | |
761 | Phosphorylation | FLHEKVFTSAL---- HHHHHHHHHCC---- | 18.97 | - | |
762 | Phosphorylation | LHEKVFTSAL----- HHHHHHHHCC----- | 18.99 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FAKD5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FAKD5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FAKD5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of FAKD5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-507, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY. |